Low incidence of HHV-6 reactivation in haploidentical hematopoietic stem cell transplantation with corticosteroid as graft-vs-host disease prophylaxis compared with cord blood transplantation. 2019/06
5.
研究報告
兵庫医科大学病院における細胞治療製剤(テムセルHS注®)の管理・運用体制の構築 2019/06
6.
原著
Early evaluation of tumor response to90 2019/07
7.
原著
Predictive value of interim FDG-PET/CT findings in patients with diffuse large B-cell lymphoma treated with R-CHOP. 2019/09
8.
研究報告
細胞治療製剤(テムセルHS注®)の生細胞率測定による品質評価 2020/01
9.
原著
Allogeneic hematopoietic stem cell transplantation from a 2-HLA-haplotype-mismatched family donor for posttransplant relapse: a prospectiv phaseⅠ/Ⅱ study 2020/06
10.
原著
Treatment strategy in a patient showing borderline features between plasmablastic lymphoma and plasmablastic myeloma harboring a 17p deletion 2020/06
11.
原著
High Prevalence of PNH-phenotype Cells in Patients Who Received CD19-targeted CAR T-cell Therapy 2021/09
12.
原著
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia 2021/10
13.
症例報告
Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma 2021/12
14.
症例報告
T-cell lymphoma, B-cell lymphoma, and myelodysplastic syndrome harboring common mutations: Trilineage tumorigenesis from a common founder clone 2022/02
15.
原著
A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy. 2022/07
Association between the grade of cytokine release syndrome and cardiac dysfunction after chimeric antigen receptor T cell therapy for diffuse large B cell lymphoma patients. (ポスター掲示,一般) 2021/11/13
74.
CAR-T細胞療法における細胞調製施設の構築と清浄度維持 (口頭,一般) 2021/11/20
75.
初発時に急激な白血球(骨髄系細胞)増加を伴ったMPALの1例 (口頭,一般) 2021/11/27
76.
腎移植後に成人T細胞白血病を発症した一例 (ポスター掲示,一般) 2022/02/24
77.
The Association between Grade of Cytokine Release Syndrome and Cardiac Dysfunction after Chimeric Antigen Receptor T Cell Therapy. (口頭,シンポジウム・ワークショップ パネル(その他)) 2022/03/12
Grade Of CRS Is Associated With Cardiac Dysfunction In The Acute Phase, But Do Not Predict The Prognosis Of Difuse Large B Cell Lymphoma Patients Who Underwent CAR-T Therapy. (ポスター掲示,一般) 2022/11/06